Douglas Bucklin Ph.D. Moderating Panel at Life Sciences Masters 2022


On October 26, 2022, Senior Attorney Douglas Bucklin, Ph.D. will be moderating a panel discussing the impact of GSK v. Teva on "skinny labeling," subsequent cases, and industry considerations.

The panel discussion Strategic Considerations for Generics and Brands in Light of GSK v. Teva is part of IP Watchdog’s Inaugural Life Sciences Masters program. The panelists include Emer Simico of Neal Gerber Eisenberg, Melissa Brand with Radius Health Inc. and Luke Shannon of Polsinelli.

Jump to Page

By using this site, you agree to our updated Privacy Policy & Disclaimer.